LoginRegister

    Suven Life Sciences gets patents from India, US, Hong Kong on neurological molecule

    Written by Ruby Khatun Khatun   |  

    New Delhi: Suven Life Sciences said it has been granted a patent each from Hong Kong and the US and two from India for treatment of disorders associated with neurodegenerative diseases.


    The patents are valid till 2032, 2030 and 2034, respectively, the company said in a BSE filing.


    "We are very pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS (central nervous system) arena, which is being developed for cognitive disorders with high unmet medical need with a huge market potential globally," Suven Life CEO Venkat Jasti said.


    The granted claims of the patents are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's, attention deficit hyperactivity disorder (ADHD), Huntington's disease, Parkinson's and Schizophrenia.

    Alzheimerattention deficit hyperactivity disorderCentral Nervous SystemCNSHong KongHuntington’s diseaseIndiaindian pharma newsneurodegenerative diseasesneurological moleculeParkinson'spatentspharma newspharma news indiaschizophreniaSuvenSuven LifeSuven Life SciencesUSVenkat Jasti
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      sidekick